TickerLeague.com
Biogen Inc. logo

Biogen

BIIB

Healthcare
NASDAQ
US
CIK:0000875045

About Biogen

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for s…

Power Profile

Revenue Counter

Biogen earns $311.09/sec (TTM: $9.81B)

Revenue counter

Earnings Counter

Biogen earns $41.01/sec net profit (TTM: $1.29B)

Earnings counter

Economic Scale

Biogen revenue exceeds Bermuda GDP ($9.2B)

Economic scale

What If Invested

See what $1,000 invested in Biogen would be worth today

What if invested

How it makes money

Visual revenue breakdown: how Biogen generates income and where it flows

How it makes money

Seasonality

Monthly and quarterly returns heatmap, seasonality matrix for Biogen

View seasonality
Q1 2026
Report Date
Apr 30, 2026
BMO
Lock in
43 days 4 hours
Revenue
Analyst Forecast
$2.24B
EPS
Analyst Forecast
3.04